To the central content area
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

4171 GeneReach
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Cheng-Chung Liu De-Yu Zhong Yu Yen Fu 04-24639869 No.19,Keyuan 2nd Road,Central Taiwan Science Park,Taichung City,Taiwan R.O.C 2014/08/14
Industry Main Business
Agricultural Technology Industry GeneReach Biotechnology Corporation is a worldwide biotechnology company dedicated to bringing the innovation to global health management. By developing, manufacturing and marketing products for applied nucleic acid detection technology, we offer disease detection platforms, including equipments and reagents, to multiple industries. Our products are currently in aquaculture, agriculture and companion animal industries. In the near future, we will launch the diagnostic kits for livestock and human. Since its commencement, GeneReach Biotechnology Corporation has set the goal to become the best company in molecular diagnosis industry. Specifically, our mission is to provide the best and affordable molecular diagnostics to the point of care market, and our vision is enriching your life. We believe our platform technologies will revolutionize health management industry. Through our platform technologies, we will help more lives and guarantee satisfied customers.
Market Information ( 2023/02/06 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
630.361 64.50  63.10  64.00  0.90  641 1,961 178
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.